Cited by 187Antibiotic Use and ResistanceAntibiotics Pharmacokinetics and EfficacySepsis Diagnosis and Treatment

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index, and 1 are not checked yet.

Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis

Open access

Havey, Thomas C, Fowler, Robert A, Daneman, Nick·2011·Critical Care

DOI 10.1186/cc10545PMC PMC3388653

Open this paper in CoChat — free account Open PDF

Abstract

Introduction: The optimal duration of antibiotic therapy for bloodstream infections is unknown. Shorter durations of therapy have been demonstrated to be as effective as longer durations for many common infections; similar findings in bacteremia could enable hospitals to reduce antibiotic utilization, adverse events, resistance and costs. Methods: A search of the MEDLINE, EMBASE and COCHRANE databases was conducted for the years 1947-2010. Controlled trials were identified that randomized patients to shorter versus longer durations of treatment for bacteremia, or the infectious foci most commonly causing bacteremia in critically ill patients (catheter-related bloodstream infections (CRBSI), intra-abdominal infections, pneumonia, pyelonephritis and skin and soft-tissue infections (SSTI)). Results: Twenty-four eligible trials were identified, including one trial focusing exclusively on bacteremia, zero in catheter related bloodstream infection, three in intra-abdominal infection, six in pyelonephritis, thirteen in pneumonia and one in skin and soft tissue infection. Thirteen studies reported on 227 patients with bacteremia allocated to 'shorter' or 'longer' durations of treatment. Outcome data were available for 155 bacteremic patients: neonatal bacteremia ( n = 66); intra-abdominal infection (40); pyelonephritis (9); and pneumonia (40). Among bacteremic patients receiving shorter (5-7 days) versus longer (7-21 days) antibiotic therapy, no significant difference was detected with respect to rates of clinical cure (45/52 versus 47/49, risk ratio 0.88, 95% confidence interval [CI] 0.77-1.01), microbiologic cure (28/28 versus 30/32, risk ratio 1.05, 95% CI 0.91-1.21), and survival (15/17 versus 26/29, risk ratio 0.97, 95% CI 0.76-1.23). Conclusions: No significant differences in clinical cure, microbiologic cure and survival were detected among bacteremic patients receiving shorter versus longer duration antibiotic therapy. An adequately powered randomized trial of bacteremic patients is needed to confirm these findings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/cc10545

Cites

60 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Flowchart describing citations screened, studies included for searches of bacteremia, and infectious syndromes most commonly causing bacteremia. CRBSI, catheter-related bloodstream infection; SSTI, skin and soft tissue infection.CC BY · PubMed Central

Figure 2 Forest plot for outcome of clinical cure among bacteremic subgroups of randomized trials of shorter versus longer antibiotic treatment. CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel.CC BY · PubMed Central

Figure 3 Forest plot for outcome of microbiologic cure among bacteremic subgroups of randomized trials of shorter versus longer antibiotic treatment. CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel.CC BY · PubMed Central

Figure 4 Forest plot for outcome of survival among bacteremic subgroups of randomized trials of shorter versus longer antibiotic treatment. CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,182
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,932
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Liu, C., Bayer, A. S., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,260
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,639
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America.
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F. “., Everett, E. D., Dellinger, P. E., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,613

Show all 60 references

Sorted by citations

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
Weiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,304
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children
Weiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 663
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O’Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 604
Bloodstream infections in critically ill patients: an expert statement
Timsit, J., Ruppé, É., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 487
Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial
Yahav, D., Franceschini, E., Koppel, F., Turjeman, A., Babich, T., Bitterman, R., Neuberger, A., Ghanem-Zoubi, N., Santoro, A., Eliakim-Raz, N., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1054 · Cited by 433
Antibiotic stewardship in the intensive care unit
Luyt, C. E., Bréchot, N., Trouillet, J., & Chastre, J. E. (2014) · Critical Care · doi:10.1186/s13054-014-0480-6 · Cited by 409
The dormant blood microbiome in chronic, inflammatory diseases
Potgieter, M., Bester, J., Kell, D. B., & Pretorius, E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv013 · Cited by 384
2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & GIORGIO, R. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 342
Clinical Utility and Measurement of Procalcitonin.
Samsudin, I. N., & Vasikaran, S. D. (2017) · Europe PMC (PubMed Central) · Cited by 217
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases
de With, K., Allerberger, F. J., Amann, S., Apfalter, P., Brodt, H.-R., Eckmanns, T., Fellhauer, M., Geiss, H. K., Janata, O., Krause, R. G. E., et al. (2016) · Infection · doi:10.1007/s15010-016-0885-z · Cited by 217
Management of KPC-producing Klebsiella pneumoniae infections
Bassetti, M., Giacobbe, D. R., Giamarellou, H., Viscoli, C., Daikos, G. L., Dimopoulos, G., Rosa, F. G. D., Giamarellos‐Bourboulis, E. J., Rossolini, G. M., Righi, E., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.030 · Cited by 175
Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort
Chotiprasitsakul, D., Han, J., Cosgrove, S. E., Harris, A. D., Lautenbach, E., Conley, A. T., Tolomeo, P., Wise, J. A., Tamma, P. D., & Antibacterial Resistance Leadership Group (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix767 · Cited by 173
Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation
Campion, M. G., & Scully, G. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618762747 · Cited by 179
Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections
The BALANCE Investigators (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2404991 · Cited by 158
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial
Molina, J., Montero-Mateos, E., Praena-Segovia, J., León-Jiménez, E., Natera, C., López-Cortés, L. E., Valiente, L., Rosso-Fernández, C. M., Herrero, M., Aller-García, A. I., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.001 · Cited by 147
Next generation sequencing for diagnosis of severe pneumonia: China, 2010–2018
Xie, Y., Du, J., Jin, W., Teng, X., Cheng, R., Huang, P., Xie, H., Zhou, Z., Tian, R., Wang, R., et al. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.09.004 · Cited by 138
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis
Curran, J., Lo, J., Leung, V., Brown, K. A., Schwartz, K. L., Daneman, N., Garber, G. E., Wu, J. H., & Langford, B. J. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.022 · Cited by 138
Self-citation
Advances in antibiotic therapy in the critically ill
Vincent, J., Bassetti, M., François, B., Karam, G. H., Chastre, J. E., Torres, A., Roberts, J. A., Taccone, F. S., Rello, J., Calandra, T., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1285-6 · Cited by 136
No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases
Kell, D. B., & Pretorius, E. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12407 · Cited by 117
Bloodstream infections in the Intensive Care Unit
Bassetti, M., Righi, E., & Carnelutti, A. (2016) · Virulence · doi:10.1080/21505594.2015.1134072 · Cited by 112
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting
Albrich, W. C., & Harbarth, S. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3978-8 · Cited by 96
Shorter versus longer courses of antibiotics for infection in hospitalized patients: A systematic review and meta-analysis.
Royer, S., DeMerle, K. M., Dickson, R. P., & Prescott, H. C. (2018) · Journal of Hospital Medicine · doi:10.12788/jhm.2905 · Cited by 94
Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021
Ewig, S., Kolditz, M., Pletz, M. W., Altiner, A., Albrich, W. C., Drömann, D., Flick, H., Gatermann, S. G., Krüger, S., Nehls, W., et al. (2021) · Pneumologie · doi:10.1055/a-1497-0693 · Cited by 98
Treatment of bloodstream infections in ICUs
Timsit, J., Soubirou, J.-F., Voiriot, G., Chemam, S., Neuville, M., Mourvillier, B., Sonneville, R., Mariotte, É., Bouadma, L., & Wolff, M. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-489 · Cited by 90
Management and Prevention of Central Venous Catheter-Related Infections in the ICU
Buetti, N., & Timsit, J. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693705 · Cited by 85
Optimizing Antimicrobial Drug Dosing in Critically Ill Patients
Póvoa, P. M. S. R., Moniz, P., Gonçalves-Pereira, J., & Coelho, L. (2021) · Microorganisms · doi:10.3390/microorganisms9071401 · Cited by 87
Proposal for shorter antibiotic therapies
Wintenberger, C., Guery, B. P., Bonnet, É., Castan, B., Cohen, R., Diamantis, S., Lesprit, P., Maulin, L., Pean, Y., Péju, E., et al. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.01.007 · Cited by 79
Antimicrobial stewardship in the intensive care unit
Türe, Z., Güner, R., & Alp, E. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.10.001 · Cited by 75
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)
Bretonnière, C., Léone, M., Milési, C., Allaouchiche, B., Armand-Lefèvre, L., Baldési, O., Bouadma, L., Decré, D., Figueiredo, S., Gauzit, R., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3853-7 · Cited by 73
Duration of antibiotic therapy in the intensive care unit
Zilahi, G., McMahon, A., Póvoa, P. M. S. R., & Martín‐Loeches, I. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.89 · Cited by 75
Guidelines for Antibiotic Prescription in Intensive Care Unit
Guleria, R., Mohan, A., Kulkarni, A. P., Madan, K., & Hadda, V. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23101 · Cited by 79
Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities
Daneman, N., Campitelli, M. A., Giannakeas, V., Morris, A. M., Bell, C. M., Maxwell, C. J., Jeffs, L. P., Austin, P. C., & Bronskill, S. E. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.161437 · Cited by 69
Self-citation
Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams
Mercuro, N. J., Stogsdill, P., & Wungwattana, M. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.12.007 · Cited by 64
Routine antibiotic therapy in dogs increases the detection of antimicrobial-resistant faecal Escherichia coli
Schmidt, V. M., Pinchbeck, G. L., McIntyre, K. M., Nuttall, T. J., McEwan, N. R., Dawson, S., & Williams, N. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky352 · Cited by 64
Opportunities and challenges to improving antibiotic prescribing practices through a One Health approach: results of a comparative survey of doctors, dentists and veterinarians in Australia
Zhuo, A., Labbate, M., Norris, J. M., Gilbert, G. L., Ward, M. P., Bajorek, B. V., Degeling, C., Rowbotham, S. J., Dawson, A., Nguyen, K.-A. T., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020439 · Cited by 62
Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections
Nelson, A. N., Justo, J. A., Bookstaver, P. B., Kohn, J. E., Albrecht, H., & Al‐Hasan, M. N. (2017) · Infection · doi:10.1007/s15010-017-1020-5 · Cited by 61
Variation in Current Management of Term and Late-preterm Neonates at Risk for Early-onset Sepsis
van Herk, W., el Helou, S., Janota, J., Hagmann, C. F., Klingenberg, C., Staub, E., Giannoni, É., Tissières, P., Schlapbach, L. J., van Rossum, A. M. C., et al. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001063 · Cited by 58
The Benefits and Harms of Antibiotic Prophylaxis for Urinary Tract Infection in Older Adults
Langford, B. J., Brown, K. A., Diong, C. C., Marchand‐Austin, A., Adomako, K., Saedi, A., Schwartz, K. L., Johnstone, J., MacFadden, D. R., Matukas, L. M., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab116 · Cited by 58
Self-citation
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway
Global Alliance for Infections in Surgery Working Group, Sartelli, M., Kluger, Y., Ansaloni, L., Carlet, J. M., Brink, A. J., Hardcastle, T. C., Khanna, A. K., Chicom-Mefire, A., Rodríguez‐Baño, J., et al. (2017) · Surgical Infections · doi:10.1089/sur.2017.219 · Cited by 57
7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial
on behalf of the Canadian Critical Care Trials Group, Daneman, N., Rishu, A. H., Pinto, R. L., Aslanian, P., Bagshaw, S. M., Carignan, A., Charbonney, E., Coburn, B. A., Cook, D. J., et al. (2018) · Trials · doi:10.1186/s13063-018-2474-1 · Cited by 58
Self-citation
Host Diagnostic Biomarkers of Infection in the ICU: Where Are We and Where Are We Going?
Heffernan, A. J., & Denny, K. J. (2021) · Current Infectious Disease Reports · doi:10.1007/s11908-021-00747-0 · Cited by 56
Estimated Clinical and Economic Impact through Use of a Novel Blood Collection Device To Reduce Blood Culture Contamination in the Emergency Department: a Cost-Benefit Analysis
Skoglund, E. W., Dempsey, C. J., Chen, H., & Garey, K. W. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01015-18 · Cited by 52
Utility of Blood Cultures in Pneumonia
Zhang, D., Yang, D., & Makam, A. N. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.025 · Cited by 53
Impact of a restrictive antibiotic policy on the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an endemic region: a before-and-after, propensity-matched cohort study in a Caribbean intensive care unit
Terrier, C. L., Vinetti, M., Bonjean, P., Richard, R., Jarrige, B., Pons, B., Madeux, B., Piednoir, P., Ardisson, F., Elie, E., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03660-z · Cited by 47
Duration of Antimicrobial Treatment for Bacteremia in Canadian Critically Ill Patients*
Daneman, N., Rishu, A. H., Xiong, W. G., Bagshaw, S. M., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., Lauzier, F., Marshall, J. C., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001393 · Cited by 46
Self-citation
Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers
Intensiva, O. B. O. N. –. N. I. D. I. E. M., Borges, I. N., Carneiro, R. M., Bergo, R., Martins, L. N. A., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C. G., et al. (2020) · Critical Care · doi:10.1186/s13054-020-02946-y · Cited by 44
Short- versus long-course therapy in gram-negative bacilli bloodstream infections
Sousa, A., Pérez-Rodríguez, M. T., Suárez, M., Val, N., Martínez-Lamas, L., Nodar, A., Longueira, R., & Casal, M. C. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03467-5 · Cited by 43
Management of neonatal sepsis in term newborns
Pont‐Thibodeau, G. D., Joyal, J., & Lacroix, J. (2014) · F1000Prime Reports · doi:10.12703/p6-67 · Cited by 43
Update on bloodstream infections in ICUs
Timsit, J., & Laupland, K. B. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328356cefe · Cited by 41
Duration of Antibiotic Therapy for Critically Ill Patients with Bloodstream Infections: A Retrospective Cohort Study
Havey, T., Fowler, R., Pinto, R. L., Elligsen, M., & Daneman, N. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/141989 · Cited by 39
Self-citation
Seven versus 10 days antibiotic therapy for culture‐proven neonatal sepsis: A randomised controlled trial
Rohatgi, S., Dewan, P., Faridi, M., Kumar, A., Malhotra, R. K., & Batra, P. (2017) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13518 · Cited by 38
Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit
Gilbert, D. N. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.003 · Cited by 38
Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia
Park, S. H., Milstone, A. M., Diener‐West, M., Nussenblatt, V. R., Cosgrove, S. E., & Tamma, P. D. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt424 · Cited by 37
Year in review 2011: Critical Care - infection
Afshari, A., Pagani, L., & Harbarth, S. (2012) · Critical Care · doi:10.1186/cc11421 · Cited by 37
Pathogenic bacteria distributions and drug resistance analysis in 96 cases of neonatal sepsis
Dong, H., Cao, H., & Zheng, H. (2017) · BMC Pediatrics · doi:10.1186/s12887-017-0789-9 · Cited by 36
Bakterielle Sepsis
Richter, D., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Krüger, W. A., et al. (2017) · Der Anaesthesist · doi:10.1007/s00101-017-0363-8 · Cited by 35
Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care
Onakpoya, I., Walker, A. S., Tan, P. S., Spencer, E. A., Gbinigie, O. A., Cook, J., Llewelyn, M., & Butler, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194858 · Cited by 34
Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections
Esposito, S., Esposito, I., & Leone, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks277 · Cited by 34
Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review
Corona, A., Santis, V. D., Agarossi, A., Prete, A., Cattaneo, D., Tomasini, G., Bonetti, G., Patroni, A., & Latronico, N. (2023) · Antibiotics · doi:10.3390/antibiotics12081262 · Cited by 33
Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia
Ong, D. S. Y., Bonten, M. J. M., Safdari, K., Spitoni, C., Frencken, J. F., Witteveen, E., Horn, J., Klouwenberg, P. M. C. K., & Cremer, O. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ560 · Cited by 33
Duration of antibiotic therapy for common infections
Grant, J., & Saux, N. L. (2021) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2021-04-29 · Cited by 39
The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
Sieswerda, E., Bax, H. I., Hoogerwerf, J. J., de Boer, M. G. J., Boermeester, M. A., Bonten, M. J. M., Dekker, D., van Wijk, R. G., Juffermans, N. P., Kuindersma, M., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07653-3 · Cited by 30
Microbial contamination of transplant solutions during pancreatic islet autotransplants is not associated with clinical infection in a pediatric population
Berger, M. G., Majumder, K., Hodges, J. S., Bellin, M. D., Schwarzenberg, S. J., Gupta, S., Dunn, T. B., Beilman, G. J., Pruett, T. L., Freeman, M. L., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.019 · Cited by 30
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial
on behalf of the Canadian Critical Care Trials Group, Daneman, N., Rishu, A. H., Xiong, W., Bagshaw, S. M., Cook, D. J., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., et al. (2015) · Trials · doi:10.1186/s13063-015-0688-z · Cited by 29
Self-citation
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocol
Daneman, N., Rishu, A. H., Pinto, R. L., Arabi, Y. M., Cook, D. J., Hall, R., McGuinness, S., Muscedere, J., Parke, R. L., Reynolds, S., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038300 · Cited by 28
Self-citation
Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies
Felice, V. G.-D., Ефимова, Е. А., Izmailyan, S., Napolitano, L. M., & Chopra, T. (2020) · Surgical Infections · doi:10.1089/sur.2020.241 · Cited by 28
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
Walsh, T., Bremmer, D. N., Moffa, M. A., Trienski, T. L., Buchanan, C., Stefano, K., Hand, C., Taylor, T., Kasarda, K., Shively, N. R., et al. (2021) · Infection · doi:10.1007/s15010-021-01581-1 · Cited by 28
The role of antimicrobials in the treatment of sepsis and critical illness‐related bacterial infections: Examination of the evidence
Keir, I., & Dickinson, A. E. (2015) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12272 · Cited by 26
Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013
Santis, V. D., Gresoiu, M., Corona, A., Wilson, A. P. R., & Singer, M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku338 · Cited by 27
Dose modulation: A new concept of antibiotic therapy in the critically ill patient?
Gonçalves-Pereira, J., & Paiva, J.-A. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.11.018 · Cited by 25
Shorter Duration of Post-Operative Antibiotics for Cecal Ligation and Puncture Does Not Increase Inflammation or Mortality
Iskander, K. N., Vaickus, M. H., Duffy, E. R., & Remick, D. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163005 · Cited by 26
Are infection specialists recommending short antibiotic treatment durations? An ESCMID international cross-sectional survey.
Macheda, G., Dyar, O. J., Luc, A., Beovic, B., Béraud, G., Castan, B., Gauzit, R., Lesprit, P., Tattevin, P., Thilly, N., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx528 · Cited by 24
A cross-sectional study evaluating the knowledge and beliefs about, and the use of antibiotics amongst Malaysian university students
Haque, M., Rahman, N. A. A., McKimm, J., Abdullah, S. L. B., Islam, M. Z., Zulkifli, Z., Saidin, N. B., Azhar, N. I. K., Lutfi, S. N. N. B., & Othman, N. S. A. B. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1581607 · Cited by 26
The Italian Society of Internal Medicine choosing wisely campaign
Montano, N., Costantino, G., Casazza, G., Sbrojavacca, R., Lenti, M. V., Falsetti, L., Guzzo, A. S., MAJO, R., Perticone, F., & Corazza, G. R. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1560-1 · Cited by 22
Factors associated with recurrence and mortality in central line-associated bloodstream infections: a retrospective cohort study
Huerta, L. E., Nelson, G. E., Stewart, T. G., & Rice, T. W. (2018) · Critical Care · doi:10.1186/s13054-018-2206-7 · Cited by 22
Antibiotic use in critical illness
Stewart, S. D., & Allen, S. J. (2019) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12842 · Cited by 22
The evidence base for the optimal antibiotic treatment duration of upper and lower respiratory tract infections: an umbrella review
Kuijpers, S. M. E., Buis, D. T. P., Ziesemer, K. A., van Hest, R. M., Schade, R. P., Sigaloff, K., & Prins, J. M. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00456-0 · Cited by 24
Stopping the effective non-fluoroquinolone antibiotics at day 7 vs continuing until day 14 in adults with acute pyelonephritis requiring hospitalization: A randomized non-inferiority trial
Rudrabhatla, P. K., Deepanjali, S., Mandal, J., Swaminathan, R. P., & Kadhiravan, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197302 · Cited by 21
Knowing when to stop antibiotic therapy
Gilbert, G. L. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.01201 · Cited by 21
How to choose the duration of antibiotic therapy in patients with pneumonia
Aliberti, S., Giuliani, F., Ramírez, J. A., & Blasi, F. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000140 · Cited by 20
Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomes
Kang, A. Y., Beuttler, R., & Minejima, E. (2022) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211073248 · Cited by 20
The JAID/JSC guidelines for management of infectious diseases 2017 – Sepsis and catheter-related bloodstream infection
Arakawa, S., Kasai, M., Kawai, S., Sakata, H., & Mayumi, T. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.11.011 · Cited by 20
Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization
Brigmon, M. M., Bookstaver, P. B., Kohn, J. E., Albrecht, H., & Al‐Hasan, M. N. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.05.013 · Cited by 20
Significant Publications on Infectious Diseases Pharmacotherapy in 2017
Skoglund, E. W., Dotson, K. M., Dempsey, C. J., Su, C. P., Foolad, F., Janak, C. E., Sofjan, A. K., & Phe, K. (2018) · Journal of Pharmacy Practice · doi:10.1177/0897190018792797 · Cited by 19
Post-Cholecystectomy Mirizzi Syndrome: A Case Report and Review of the Literature
Borz-Baba, C., Levy, D. A., & Cohen, M. E. (2019) · American Journal of Case Reports · doi:10.12659/ajcr.916364 · Cited by 18
Short- versus long-course antibiotic therapy for sepsis: a post hoc analysis of the nationwide cohort study
Takahashi, N., Imaeda, T., Nakada, T., Oami, T., Abe, T., Yamao, Y., Nakagawa, S., Ogura, H., Shime, N., Matsushima, A., et al. (2022) · Journal of Intensive Care · doi:10.1186/s40560-022-00642-3 · Cited by 17
Bacterial sepsis
Richter, D., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Krüger, W. A., et al. (2018) · Der Anaesthesist · doi:10.1007/s00101-017-0396-z · Cited by 18
Shortening the course of antibiotic treatment in the intensive care unit
Barrett, J., Edgeworth, J., & Wyncoll, D. L. A. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1008451 · Cited by 15
Rapid Bacterial Detection and Gram-Identification Using Bacterially Activated, Macrophage-Membrane-Coated Nanowired-Si Surfaces in a Microfluidic Device
Liu, S., Wang, H., Yu, L., Ren, Y., Bouma, H. R., Liu, J., van der Mei, H. C., & Busscher, H. J. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c02686 · Cited by 16
Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trial (SATIE)
Olmos, C., Vilacosta, I., López, J., Sáez, C., Anguita, M. P., García-Granja, P. E., Sarriá, C., Silva, J., Álvarez, B. Á., Martínez-Monzonis, M. A., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05132-1 · Cited by 16
Short‐course versus long‐course antibiotic treatment in patients with uncomplicated gram‐negative bacteremia: A systematic review and meta‐analysis
Li, X., Liu, C., Mao, Z., Li, Q., Qi, S., & Zhou, F. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13277 · Cited by 16
Relevance of blood cultures in acute pyelonephritis in a single-center retrospective study
Ledochowski, S., Abraham, P.-S., Jacob, X., Dumitrescu, O., Lina, G., Lepape, A., Piriou, V., Wallet, F., & Friggeri, A. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1223-7 · Cited by 15
Antibiotic treatment durations for pyogenic liver abscesses: A systematic review
Curran, J., Mulhall, C., Pinto, R. L., Bucheeri, M. A., & Daneman, N. (2023) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2023-0004 · Cited by 14
Self-citation
Sepsis and Total Joint Arthroplasty
Patel, K. M., Mears, S. C., Barnes, C. L., Stambough, J. B., & Stronach, B. M. (2021) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2021.08.008 · Cited by 14
An evaluation of antibiotic prescribing patterns in adult intensive care units in a private hospital in KwaZulu-Natal
Chunnilall, D., Peer, A. K. C., Naidoo, I., & Essack, S. Y. (2015) · Southern African Journal of Infectious Diseases · doi:10.1080/23120053.2015.1103956 · Cited by 14
A Practical Approach to Clinical Antibiotic Stewardship in the ICU Patient with Severe Infection
Fierens, J., Depuydt, P. O., & Waele, J. J. D. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693995 · Cited by 14
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program
Maher, J. M., Huband, M. D., Blankers, C. G., Puttagunta, S., Aronin, S. I., & Castanheira, M. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad099 · Cited by 13
Machine learning-derived blood culture classification with both predictive and prognostic values in the intensive care unit: A retrospective cohort study
Zhang, J., Liu, W., Xiao, W., Liu, Y., Hua, T., & Yang, M. (2023) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2023.103549 · Cited by 13

Authors: Havey, T. C., Fowler, R. A., & Daneman, N.
Affiliations: University of Toronto (CA)
Sunnybrook Health Science Centre (CA)
Corresponding author: Daneman, Nick
ORCID: Fowler, Robert A
Daneman, Nick
Venue: Critical Care
Publisher: Springer Science and Business Media LLC
Published: 2011-11-15
Volume: 15
Issue: 6
Pages: R267-R267
ISSN: 1364-8535 (ISSN-L)
DOI: 10.1186/cc10545
PMC: PMC3388653
OpenAlex: W2146470820
Cited by: 187
References: 60
Citations by year: 2026: 3 · 2025: 11 · 2024: 6 · 2023: 16 · 2022: 12 · 2021: 21 · 2020: 19 · 2019: 14 · 2018: 19 · 2017: 19 · 2016: 11 · 2015: 20 · 2014: 7 · 2013: 5 · 2012: 4
FWCI: 0.59
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/2.0/ (tdm)
creativecommons.org/licenses/by/2.0/ (vor)
Locations: Critical Care (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
TSpace (University of Toronto) (submittedVersion)
Funders: Heart and Stroke Foundation of Canada
Ontario Ministry of Health and Long-Term Care
Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords: bacteremia, antibiotic duration, short-course antibiotic therapy, bloodstream infection, clinical cure, microbiologic cure, survival, catheter-related bloodstream infection, intra-abdominal infection, pyelonephritis, pneumonia, skin and soft tissue infections, neonatal bacteremia, antibiotic use
MeSH terms: Anti-Bacterial Agents, Humans, Pyelonephritis, Time Factors, Bacteremia, Pneumonia, Bacterial, Soft Tissue Infections, Catheter-Related Infections, Intraabdominal Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks